Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

Glioblastoma (GBM) is the most frequent primary malignant brain tumor and has a dismal prognosis. Unfortunately, despite the recent revolution of immune checkpoint inhibitors in many solid tumors, these have not shown a benefit in overall survival in GBM patients. Therefore, new potential treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Bosch, Neus, Vilariño, Noelia, Alameda, Francesc, Mojal, Sergi, Arumí-Uria, Montserrat, Carrato, Cristina, Aldecoa, Iban, Ribalta, Teresa, Vidal, Noemí, Bellosillo, Beatriz, Menéndez, Silvia, Del Barco, Sonia, Gallego, Oscar, Pineda, Estela, López-Martos, Raquel, Hernández, Ainhoa, Mesia, Carlos, Esteve-Codina, Anna, de la Iglesia, Nuria, Balañá, Carme, Martínez-García, María, Navarro, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047329/
https://www.ncbi.nlm.nih.gov/pubmed/36980184
http://dx.doi.org/10.3390/cells12060843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047329/
https://www.ncbi.nlm.nih.gov/pubmed/36980184
http://dx.doi.org/10.3390/cells12060843

Ejemplares similares